Washington Trust Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956 | Hold |
127
| – | – | ﹤0.01% | 626 |
|
|
2025
Q1 | $961 | Hold |
127
| – | – | ﹤0.01% | 630 |
|
|
2024
Q4 | $1.55K | Hold |
127
| – | – | ﹤0.01% | 627 |
|
|
2024
Q3 | $2.13K | Hold |
127
| – | – | ﹤0.01% | 633 |
|
|
2024
Q2 | $2.22K | Hold |
127
| – | – | ﹤0.01% | 628 |
|
|
2024
Q1 | $2.17K | Hold |
127
| – | – | ﹤0.01% | 637 |
|
|
2023
Q4 | $1.3K | Hold |
127
| – | – | ﹤0.01% | 654 |
|
|
2023
Q3 | $1.15K | Hold |
127
| – | – | ﹤0.01% | 659 |
|
|
2023
Q2 | $1.37K | Buy |
127
+56
| +79% | +$603 | ﹤0.01% | 642 |
|
|
2023
Q1 | $727 | Hold |
71
| – | – | ﹤0.01% | 766 |
|
|
2022
Q4 | $749 | Hold |
71
| – | – | ﹤0.01% | 771 |
|
|
2022
Q3 | $1K | Hold |
71
| – | – | ﹤0.01% | 876 |
|
|
2022
Q2 | $1K | Hold |
71
| – | – | ﹤0.01% | 907 |
|
|
2022
Q1 | $1K | Hold |
71
| – | – | ﹤0.01% | 974 |
|
|
2021
Q4 | $1K | Buy |
+71
| New | +$1K | ﹤0.01% | 978 |
|